Archivio Categoria: series B

Zylo Secures $22.5M Series B

Zylo 55 Monument Circle, 14th FloorIndianapolis, IN 46204317-777-6761http://zylo.com/ Key contact Name Title Eric Christopher CEO INDIANAPOLIS, IN, Zylo, the leader in the emerging SaaS Management category, today announced the completion of a $22.5 million Series B funding round. The round was led by Menlo Ventures, with repeat investments from Bessemer Venture Partners, High Alpha, Revolution's […]

Divvy Homes Announces $43M Series B Round

Divvy Homes 633 Folsom Street, 7th FloorSan Francisco, CA 94107https://www.divvyhomes.com/ Key contact Name Title Brian Ma CEO & Co-Founder SAN FRANCISCO, CA, Divvy today announces a $43 million Series B round. Divvy, a platform that creates homeowners by building savings every month, today announces a $43-million Series B round, with GIC, Singapore’s sovereign wealth fund, […]

Terminal Lands $17M Series B

Terminal 1 Letterman DrSan Francisco, CA 94129https://terminal.io/ Key contact Name Title Clay Kellogg CEO SAN FRANCISCO, CA, Terminal, a company that builds and manages world-class remote teams to solve the tech talent shortage, today announced a Series B funding round of $17 million. The round was led by 8VC, with participation from Atomic, Cathay Innovation, […]

Eko Closes $20M in Series B

Eko Devices 2600 10th St., Suite 260Berkeley, CA 94710844-356-3384https://ekodevices.com Key contact Name Title Connor Landgraf CEO BERKELEY, CA, Eko announced it has secured $20 million in Series B funding led by ARTIS Ventures. Eko, a Silicon Valley-based digital health company building machine learning tools to fight heart disease, today announced it has secured $20 million […]

Manticore Games Pull In $30M Series B

Manticore Games 1400 Fashion Island Boulevard, Suite 303San Mateo, CA 94404650-799-6145http://www.manticoregames.com/ Key contact Name Title Frederic Descamps CEO SAN MATEO, CA, Manticore Games has raised $30 million in a Series B financing round. Manticore Games has raised $30 million in a Series B financing round. The company is developing CORE™, a digital playground and community […]

Bold Penguin Closes $32M in Series B

Bold Penguin 100 E Broad St, 15th FloorColumbus, OH 43215614-699-2114https://www.boldpenguin.com/ Key contact Name Title Ilya Bodner CEO COLUMBUS, OH, Commercial insurance technology provider, is pleased to announce it has completed a $32 Million Series B funding round. Bold Penguin, a Columbus Ohio commercial insurance technology provider, is pleased to announce it has completed a $32 […]

SKOUT CYBERSECURITY Inks $25M in Series B

SKOUT CYBERSECURITY 270 S. Service Road, Suite 55Melville, NY 11747631-203-6600https://getskout.com/ Key contact Name Title Aidan Kehoe CEO NEW YORK, NY, SKOUT CYBERSECURITY announced it has raised $25M in a Series B funding round led by ClearSky. SKOUT CYBERSECURITY, a cloud-native cybersecurity provider for small and mid-sized businesses (SMBs), delivered by managed services providers (MSPs), today […]

Edgewise Therapeutics Raises $50M Series B

Edgewise Therapeutics 3415 Colorado AveBoulder, CO 80304303-735-8373https://edgewisetx.com/ Key contact Name Title Kevin Koch, Ph.D President & CEO BOULDER, CO, Edgewise Therapeutics, a preclinical company developing small molecule therapies for musculoskeletal diseases, has announced the closing of a $50 million Series B financing round. The round was co-led by Novo Holdings A/S and U.S. Venture Partners […]

Embr Labs Scores $6M Series B Round

Embr Labs Somerville, MA 02143https://embrlabs.com/ Key contact Name Title Elizabeth Gazda CEO CAMBRIDGE, MA, Embr Labs, the breakthrough thermal technology company and creator of the Wave bracelet, today announced $6M in Series B funding. The round was led by DigiTx Partners, with participation from Safar Partners, Joyance Partners, Bose Ventures, and PBJ Capital. Embr Labs […]

Linnaeus Therapeutics Receives $12M Series B

Linnaeus Therapeutics 30 Washington Ave Suite FHaddonfield, NJ 08033856-433-1300https://linnaeustx.com/ Key contact Name Title Patrick Mooney, MD CEO HADDONFIELD, N.J., Linnaeus Therapeutics today announced that it has closed a $12 million series B financing. Linnaeus Therapeutics ("Linnaeus"), a privately held biopharmaceutical company focused on the development and commercialization of novel, small molecule oncology therapeutics, today announced […]